Navigation Links
Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
Date:6/16/2008

Director of the Cardiac Catheterization Laboratory at Scripps Clinic in La Jolla, California is the Principal Investigator for the trial. The Executive Committee comprises a group of nationally recognized physicians in the field of cardiology and includes Dr. Price, Eric Topol, MD, Paul Teirstein, MD, Peter Berger, MD, and Christopher Cannon, MD.

"The GRAVITAS trial, using the VerifyNow P2Y12 test to gauge patients' response, is prototypic of the future of individualized medicine," said Dr. Price. "Not everyone responds the same way to current antiplatelet medications, so why should we treat our patients as if they did? The results of this trial will help physicians make clinical decisions to maximize safety and improve outcomes for a large number of patients taking anti-platelet therapy."

"We are very excited that patient enrollment into the GRAVITAS trial has commenced, and we are fortunate to be working with many of the nation's leading experts in cardiology," said Steven Frankel, Accumetrics CEO. "We believe that the results from GRAVITAS will provide a more thorough understanding of how patients respond to their antiplatelet therapy, and further substantiate that individualized therapy is more effective than a one-size-fits-all approach."

About the VerifyNow P2Y12 Test:

The VerifyNow P2Y12 test is a whole blood point-of-care assay that is used to measure the level of P2Y12 receptor blockade. The GRAVITAS trial is being conducted under an Investigational Device Exemption from the U.S. FDA.

About Accumetrics (http://www.accumetrics.com):

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

VerifyNow is the first simple and rapid system for measuring th
'/>"/>

SOURCE Accumetrics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
2. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
3. Disc Motion Technologies Announces First Human Implants of True TSMS(TM) Device
4. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
5. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
6. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
7. XTENT Announces European Regulatory Update
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
10. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
11. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... board of directors of Eli Lilly and Company (NYSE: ... the first quarter of 2010 of $0.49 a share ... is payable March 10, 2010 to shareholders of record ... 12, 2010. ,, Lilly, a leading innovation-driven corporation, is ... the latest research from its own worldwide laboratories and ...
(Date:12/14/2009)... Dec. 14 Zargis Medical Corp., a ... ) and a spin-off from Siemens Corporate Research ... it has begun selling its award-winning Zargis Cardioscan(TM) ... Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope were ... "2009 Innovation of the Year." Cardioscan ...
(Date:12/14/2009)... Gibraltar Associates, a leading public ... domestic communications and issues management, today announced ... PositiveID Corporation (Nasdaq: PSID ) to ... of record. Gibraltar Associates will conduct media ... the Company on its public relations programs. ...
Breaking Medicine Technology:Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 1Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 2Philadelphia Born Ronald McDonald House 28R 29 Program Celebrates 35 Years 59433 3Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 1Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 2Bionovo Adds Dr Debu Tripathy to Their Medical Advisory Board 59431 3Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 1Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 2Dr Floyd Bloom Joins aTyr Pharmas Scientific Advisory Board 14466 3
(Date:12/14/2009)... bump in odds is small and shouldn,t worry most ... -- Older women who take antidepressants may have a ... death compared to women not on the medications, a ... different from clinical significance," stressed Dr. Jordan W. Smoller, ... and lead author of a report in the Dec. ...
(Date:12/14/2009)... 2 diabetes and obesity are linked to an increased ... that insulin glargine (a synthetic insulin preparation marketed under ... higher risk of certain cancers than other insulins or ... unable to control for important factors such as obesity ... the other hand, a large randomized trial designed to ...
(Date:12/14/2009)... functioning , , , MONDAY, Dec. 14 (HealthDay News) -- ... live longer than those who look older than their ... from research that involved 1,826 Danish twins, aged 70 ... and then had their faces photographed. Three groups of ... they perceived the participants to be. Twins were assessed ...
(Date:12/14/2009)... and the United Nations Foundation’s Nothing But Nets tipped off a ... HP--to send anti-malaria bed nets to refugees in 11 African countries. ... and runs through January 31, 2010. , ... ... National Basketball Association (NBA) and the United Nations Foundation’s Nothing But ...
(Date:12/14/2009)... Concetta F. Conkling of Moraga, CA, retired ... has been elected Chair of the Board of Trustees ... the nearly 90-year-old organization to which Helen Keller devoted ... York with offices in San Francisco, Dallas, ... is dedicated to expanding possibilities for people with vision ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2
... Society of Cardiology (ESC) is calling for concerted action ... the World Heart Organisation (WHO). // ... full extent of the global burden of chronic diseases ... is anticipated that a global action to prevent chronic ...
... upon the foods we eat, the products we buy, the ... we spend time // . Evaluation of stimulus valence is ... uses it as a basic category for organizing information and ... to be immediate, unintentional and linked to behavioral responses. ...
... agreement in principle to enable the smooth transfer of ... is an encouraging sign for Indian bioscience. But slow ... India’s grandiose scheme to become the global hub of ... of becoming a major player. , ,Discussions in ...
... alarming rise in human cases of bird flu, causing increasing ... strong resolve in the scientific community to combat this impending ... flu has risen since October 5 when scientists from the ... reported finding similarities between the bird flu strain in Asia, ...
... dream come true for the scientists who been working hard ... expected to take an extra step ahead as it is ... as well as their offspring, are safe to eat., ... techniques, with Canadian Scientists having proved themselves following the success ...
... against, a London based leading drug company, GlaxoSmithKline for ... to the U.S. Food and Drug Administration two years ... review. This became evident last November when The FDA ... , ,The Public Citizen Group has registered a ...
Other Medicine News:Health News:Conditioning preferences in children 2Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:FDA Mislead On Asthma Drug By GlaxoSmithKline 2
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
... TREK™ Compact Compressor is for active patients ... anywhere and everywhere. The compressor is small ... source optionsworldwide AC compatibility (100 to 240V), ... patients the freedom to take aerosol treatments ...
... ,Allied Healthcares Timeter® PCS 414 portable air compressor ... that you may wonder if its running. Youll ... a durable, mar-resistant steel case thats easy to ... 26.5 pounds. The PCS 414 has been engineered ...
Medicine Products: